Europe Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

You are here: 麻豆原创 Catalog Food & Beverages Nutraceuticals Pharma & Healthcare Healthcare

Europe Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

麻豆原创 Research Report Summary

Europe Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity report is published on December 31, 2023 and has 156 pages in it. This market research report provides information about Nutraceuticals, Food & Beverages, Healthcare, Pharma & Healthcare industry. It covers Europe market data and forecasts. It is priced starting at USD 2,700.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Europe Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0223108

Publication Date:听

December 31, 2023

笔补驳别蝉:听

156

笔耻产濒颈蝉丑别谤:听

Grace 麻豆原创 Data

颁辞耻苍迟谤颈别蝉:听

Europe

USD 2,700.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Europe clinical nutrition market was valued at $10.3 billion in 2022 and will grow by 7.8% annually over 2022-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.
Highlighted with 71 tables and 78 figures, this 156-page report 鈥淓urope Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, Dosage Form, Therapeutic Area, End User, Healthcare Setting, Distribution Channel, and Country.

Based on Substrate, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Carbohydrates
鈥� Lipids
鈥� Proteins & Amino Acids
鈥� Water & Electrolyte
鈥� Dietary Fiber
鈥� Antioxidants
鈥� Other Substrates

Based on Administration Route, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Oral or Enteral Administration
o Oral Nutrition Supplements
o Tube Feeding
鈥� Parenteral Administration
o Supplemental Parenteral Nutrition
o Total Parenteral Nutrition
o All-in-One System
o Multiple Bottle System

By Dosage Form, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Powder
鈥� Liquid
鈥� Solid and Semi-solid

By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Malnutrition
鈥� Metabolic Disorders
鈥� Gastrointestinal Disorders
鈥� Cancer
鈥� Neurology
鈥� Renal Diseases
鈥� Respiratory Diseases
鈥� Other Therapeutic Areas

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Infant
鈥� Children
鈥� Adult
鈥� Geriatrics

By Healthcare Setting, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Hospitals
鈥� Long-term Care Facilities (LTC)
鈥� 麻豆原创care
鈥� Inpatient Rehabilitation Facilities
鈥� Other Healthcare Settings

By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Institutional Sales
鈥� Supermarkets & Hypermarkets
鈥� Pharmacies
鈥� Drug Stores
鈥� Online Channels
鈥� Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Netherlands
鈥� Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Administration Route, Therapeutic Area, and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestl茅 S.A.
Nutricia Ltd
Perrigo Company Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Table of Contents

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of 麻豆原创 Research Methodology 13
1.2.2 麻豆原创 Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 麻豆原创 Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 麻豆原创 Overview and Dynamics 21
2.1 麻豆原创 Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 麻豆原创 Restraints and Challenges 37
2.4 Emerging Opportunities and 麻豆原创 Trends 40
2.5 Porter鈥檚 Fiver Forces Analysis 44
3 Segmentation of Europe 麻豆原创 by Substrate 48
3.1 麻豆原创 Overview by Substrate 48
3.2 Carbohydrates 50
3.3 Lipids 51
3.4 Proteins & Amino Acids 52
3.5 Water & Electrolyte 53
3.6 Dietary Fiber 54
3.7 Antioxidants 55
3.8 Other Substrates 56
4 Segmentation of Europe 麻豆原创 by Administration Route 57
4.1 麻豆原创 Overview by Administration Route 57
4.2 Oral or Enteral Administration 59
4.2.1 Oral Nutrition Supplements 60
4.2.2 Tube Feeding 61
4.3 Parenteral Administration 62
4.3.1 Supplemental Parenteral Nutrition 64
4.3.2 Total Parenteral Nutrition 65
4.3.3 All-in-One System 66
4.3.4 Multiple Bottle System 67
5 Segmentation of Europe 麻豆原创 by Dosage Form 68
5.1 麻豆原创 Overview by Dosage Form 68
5.2 Powder 70
5.3 Liquid 71
5.4 Solid and Semi-solid 72
6 Segmentation of Europe 麻豆原创 by Therapeutic Area 73
6.1 麻豆原创 Overview by Therapeutic Area 73
6.2 Malnutrition 75
6.3 Metabolic Disorders 76
6.4 Gastrointestinal Disorders 77
6.5 Cancer 78
6.6 Neurology 79
6.7 Renal Diseases 80
6.8 Respiratory Diseases 81
6.9 Other Therapeutic Areas 82
7 Segmentation of Europe 麻豆原创 by End User 83
7.1 麻豆原创 Overview by End User 83
7.2 Infant 85
7.3 Children 86
7.4 Adult 87
7.5 Geriatrics 88
8 Segmentation of Europe 麻豆原创 by Healthcare Setting 89
8.1 麻豆原创 Overview by Healthcare Setting 89
8.2 Hospitals 91
8.3 Long-term Care Facilities (LTC) 92
8.4 麻豆原创care 93
8.5 Inpatient Rehabilitation Facilities 94
8.6 Other Healthcare Settings 95
9 Segmentation of Europe 麻豆原创 by Distribution Channel 96
9.1 麻豆原创 Overview by Distribution Channel 96
9.2 Institutional Sales 98
9.3 Supermarkets & Hypermarkets 99
9.4 Pharmacies 100
9.5 Drug Stores 101
9.6 Online Channels 102
9.7 Other Distribution Channels 103
10 European 麻豆原创 2022-2032 by Country 104
10.1 Overview of European 麻豆原创 104
10.2 Germany 107
10.3 U.K. 109
10.4 France 111
10.5 Spain 113
10.6 Italy 115
10.7 Netherlands 117
10.8 Rest of European 麻豆原创 119
11 Competitive Landscape 121
11.1 Overview of Key Vendors 121
11.2 New Product Launch, Partnership, Investment, and M&A 124
11.3 Company Profiles 125
Abbott Nutrition 125
B Braun Melsungen Ag 127
BASF SE 130
Baxter International Inc. 133
Claris Lifesciences Ltd. 136
Fresenius Kabi Ag 137
Lonza Group AG 140
Nestl茅 S.A. 144
Nutricia Ltd 149
Perrigo Company Plc 153
RELATED REPORTS 156
鈥�

List of Tables:

Table 1. Snapshot of Europe Clinical Nutrition 麻豆原创 in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and 麻豆原创 Opportunities in Europe Clinical Nutrition 麻豆原创 40
Table 7. Europe Clinical Nutrition 麻豆原创 by Substrate, 2022-2032, $ mn 48
Table 8. Europe Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 57
Table 9. Europe Clinical Nutrition 麻豆原创: Oral or Enteral Administration by Type, 2022-2032, $ mn 59
Table 10. Europe Clinical Nutrition 麻豆原创: Parenteral Administration by Type, 2022-2032, $ mn 63
Table 11. Europe Clinical Nutrition 麻豆原创 by Dosage Form, 2022-2032, $ mn 68
Table 12. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 73
Table 13. Europe Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 83
Table 14. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting, 2022-2032, $ mn 89
Table 15. Europe Clinical Nutrition 麻豆原创 by Distribution Channel, 2022-2032, $ mn 96
Table 16. Europe Clinical Nutrition 麻豆原创 by Country, 2022-2032, $ mn 106
Table 17. Germany Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 108
Table 18. Germany Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 108
Table 19. Germany Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 108
Table 20. U.K. Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 110
Table 21. U.K. Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 110
Table 22. U.K. Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 110
Table 23. France Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 112
Table 24. France Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 112
Table 25. France Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 112
Table 26. Spain Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 114
Table 27. Spain Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 114
Table 28. Spain Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 114
Table 29. Italy Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 116
Table 30. Italy Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 116
Table 31. Italy Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 116
Table 32. Netherlands Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, $ mn 118
Table 33. Netherlands Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, $ mn 118
Table 34. Netherlands Clinical Nutrition 麻豆原创 by End User, 2022-2032, $ mn 118
Table 35. Clinical Nutrition 麻豆原创 in Rest of Europe by Country, 2022-2032, $ mn 120
Table 36. Abbott Nutrition: Company Snapshot 125
Table 37. Abbott Nutrition: Business Segmentation 126
Table 38. Abbott Nutrition: Product Portfolio 126
Table 39. B Braun Melsungen Ag: Company Snapshot 127
Table 40. B Braun Melsungen Ag: Business Segmentation 128
Table 41. B Braun Melsungen Ag: Revenue by Region 128
Table 42. B Braun Melsungen Ag: Product Portfolio 129
Table 43. BASF: Company Snapshot 130
Table 44. BASF: Business Segmentation 131
Table 45. BASF: Revenue by Region 131
Table 46. BASF: Product Portfolio 132
Table 47. Baxter International Inc.: Company Snapshot 133
Table 48. Baxter International Inc.: Business Segmentation 133
Table 49. Baxter International Inc.: Revenue by Region 134
Table 50. Baxter International Inc.: Product Portfolio 134
Table 51. Claris Lifesciences Ltd.: Company Snapshot 136
Table 52. Fresenius Kabi Ag: Company Snapshot 137
Table 53. Fresenius Kabi Ag: Business Segmentation 138
Table 54. Fresenius Kabi Ag: Revenue by Region 138
Table 55. Fresenius Kabi Ag: Product Portfolio 139
Table 56. Lonza Group: Company Snapshot 140
Table 57. Lonza Group: Business Segmentation in 2018 141
Table 58. Lonza Group: Product Portfolio 141
Table 59. Lonza Group: Revenue by Region in 2018 142
Table 60. Nestl茅 S.A.: Company Snapshot 144
Table 61. Nestl茅 S.A.: Business Segmentation 144
Table 62. Nestl茅 S.A.: Product Portfolio 145
Table 63. Nestl茅 S.A.: Revenue, 2018-2020, $ bn 147
Table 64. Nutricia Ltd: Company Snapshot 149
Table 65. Nutricia Ltd: Business Segmentation 150
Table 66. Nutricia Ltd: Revenue by Region 150
Table 67. Nutricia Ltd: Product Portfolio 151
Table 68. Perrigo Company Plc: Company Snapshot 153
Table 69. Perrigo Company Plc: Business Segmentation 154
Table 70. Perrigo Company Plc: Revenue by Region 154
Table 71. Perrigo Company Plc: Product Portfolio 154

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for 麻豆原创 Estimation 16
Figure 3. Europe 麻豆原创 Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. Europe Clinical Nutrition 麻豆原创, 2022-2032, $ mn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Nutrition 麻豆原创 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million 35
Figure 10. Primary Restraints and Impact Factors of Europe Clinical Nutrition 麻豆原创 37
Figure 11. Investment Opportunity Analysis 41
Figure 12. Porter鈥檚 Fiver Forces Analysis of Europe Clinical Nutrition 麻豆原创 44
Figure 13. Breakdown of Europe Clinical Nutrition 麻豆原创 by Substrate, 2022-2032, % of Revenue 49
Figure 14. Europe Addressable 麻豆原创 Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%) 49
Figure 15. Europe Clinical Nutrition 麻豆原创 by Substrate: Carbohydrates, 2022-2032, $ mn 50
Figure 16. Europe Clinical Nutrition 麻豆原创 by Substrate: Lipids, 2022-2032, $ mn 51
Figure 17. Europe Clinical Nutrition 麻豆原创 by Substrate: Proteins & Amino Acids, 2022-2032, $ mn 52
Figure 18. Europe Clinical Nutrition 麻豆原创 by Substrate: Water & Electrolyte, 2022-2032, $ mn 53
Figure 19. Europe Clinical Nutrition 麻豆原创 by Substrate: Dietary Fiber, 2022-2032, $ mn 54
Figure 20. Europe Clinical Nutrition 麻豆原创 by Substrate: Antioxidants, 2022-2032, $ mn 55
Figure 21. Europe Clinical Nutrition 麻豆原创 by Substrate: Other Substrates, 2022-2032, $ mn 56
Figure 22. Breakdown of Europe Clinical Nutrition 麻豆原创 by Administration Route, 2022-2032, % of Sales Revenue 58
Figure 23. Europe Addressable 麻豆原创 Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%) 58
Figure 24. Europe Clinical Nutrition 麻豆原创 by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn 59
Figure 25. Europe Clinical Nutrition 麻豆原创 by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn 60
Figure 26. Europe Clinical Nutrition 麻豆原创 by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn 61
Figure 27. Europe Clinical Nutrition 麻豆原创 by Administration Route: Parenteral Administration, 2022-2032, $ mn 62
Figure 28. Europe Clinical Nutrition 麻豆原创 by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn 64
Figure 29. Europe Clinical Nutrition 麻豆原创 by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn 65
Figure 30. Europe Clinical Nutrition 麻豆原创 by Parenteral Administration: All-in-One System, 2022-2032, $ mn 66
Figure 31. Europe Clinical Nutrition 麻豆原创 by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn 67
Figure 32. Breakdown of Europe Clinical Nutrition 麻豆原创 by Dosage Form, 2022-2032, % of Sales Revenue 69
Figure 33. Europe Addressable 麻豆原创 Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%) 69
Figure 34. Europe Clinical Nutrition 麻豆原创 by Dosage Form: Powder, 2022-2032, $ mn 70
Figure 35. Europe Clinical Nutrition 麻豆原创 by Dosage Form: Liquid, 2022-2032, $ mn 71
Figure 36. Europe Clinical Nutrition 麻豆原创 by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn 72
Figure 37. Breakdown of Europe Clinical Nutrition 麻豆原创 by Therapeutic Area, 2022-2032, % of Revenue 74
Figure 38. Europe Addressable 麻豆原创 Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 39. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Malnutrition, 2022-2032, $ mn 75
Figure 40. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn 76
Figure 41. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn 77
Figure 42. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Cancer, 2022-2032, $ mn 78
Figure 43. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Neurology, 2022-2032, $ mn 79
Figure 44. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Renal Diseases, 2022-2032, $ mn 80
Figure 45. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn 81
Figure 46. Europe Clinical Nutrition 麻豆原创 by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 82
Figure 47. Breakdown of Europe Clinical Nutrition 麻豆原创 by End User, 2022-2032, % of Revenue 84
Figure 48. Europe Addressable 麻豆原创 Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 84
Figure 49. Europe Clinical Nutrition 麻豆原创 by End User: Infant, 2022-2032, $ mn 85
Figure 50. Europe Clinical Nutrition 麻豆原创 by End User: Children, 2022-2032, $ mn 86
Figure 51. Europe Clinical Nutrition 麻豆原创 by End User: Adult, 2022-2032, $ mn 87
Figure 52. Europe Clinical Nutrition 麻豆原创 by End User: Geriatrics, 2022-2032, $ mn 88
Figure 53. Breakdown of Europe Clinical Nutrition 麻豆原创 by Healthcare Setting, 2022-2032, % of Revenue 89
Figure 54. Europe Addressable 麻豆原创 Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%) 90
Figure 55. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting: Hospitals, 2022-2032, $ mn 91
Figure 56. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn 92
Figure 57. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting: 麻豆原创care, 2022-2032, $ mn 93
Figure 58. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn 94
Figure 59. Europe Clinical Nutrition 麻豆原创 by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn 95
Figure 60. Breakdown of Europe Clinical Nutrition 麻豆原创 by Distribution Channel, 2022-2032, % of Revenue 97
Figure 61. Europe Addressable 麻豆原创 Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 97
Figure 62. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Institutional Sales, 2022-2032, $ mn 98
Figure 63. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn 99
Figure 64. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Pharmacies, 2022-2032, $ mn 100
Figure 65. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Drug Stores, 2022-2032, $ mn 101
Figure 66. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Online Channels, 2022-2032, $ mn 102
Figure 67. Europe Clinical Nutrition 麻豆原创 by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn 103
Figure 68. Breakdown of European Clinical Nutrition 麻豆原创 by Country, 2022 and 2032, % of Revenue 105
Figure 69. Contribution to Europe 2023-2032 Cumulative 麻豆原创 by Country, Value ($ mn) and Share (%) 106
Figure 70. Clinical Nutrition 麻豆原创 in Germany, 2022-2032, $ mn 107
Figure 71. Clinical Nutrition 麻豆原创 in U.K., 2022-2032, $ mn 109
Figure 72. Clinical Nutrition 麻豆原创 in France, 2022-2032, $ mn 111
Figure 73. Clinical Nutrition 麻豆原创 in Spain, 2022-2032, $ mn 113
Figure 74. Clinical Nutrition 麻豆原创 in Italy, 2022-2032, $ mn 115
Figure 75. Clinical Nutrition 麻豆原创 in Netherlands, 2022-2032, $ mn 117
Figure 76. Clinical Nutrition 麻豆原创 in Rest of Europe, 2022-2032, $ mn 119
Figure 77. Growth Stage of Europe Clinical Nutrition Industry over the Forecast Period 121
Figure 78. Nestl茅 S.A.: Revenue by Region, 2018 147

Companies Covered

Selected Key Players:
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestl茅 S.A.
Nutricia Ltd
Perrigo Company Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Region: Trend Forecast and Growth Opportunity Global clinical nutrition market will reach $107.65 billion by 2032, growing by 8.2% annually over 2022-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births. Highlighted with 120 tables and 110 figures, this 211-page report 鈥淕lobal Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from...Read more	USD 3,300.00
North America Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity North America clinical nutrition market is projected to grow by 7.6% annually in the forecast period and reach $27.64 billion by 2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births. Highlighted with 61 tables and 74 figures, this 149-page report 鈥淣orth America Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information...Read more	USD 2,700.00
Asia Pacific Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route , Dosage Form , Therapeutic Area, End User , Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity Asia Pacific clinical nutrition market will grow by 9.2% annually with a total addressable market cap of $328.51 billion over 2023-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births. Highlighted with 68 tables and 77 figures, this 155-page report 鈥淎sia Pacific Clinical Nutrition 麻豆原创 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information...Read more	USD 2,700.00
Global Nutraceuticals 麻豆原创 Research Report 2023 A food or part of a food that allegedly provides medicinal or health benefits, including the prevention and treatment of disease. A nutraceutical may be a naturally nutrient-rich or medicinally active food, or it may be a specific component of a food, such as the omega-3 fish oil that can be derived from salmon and other cold-water fish. Highlights The global Nutraceuticals market was valued at US$ 326350 million in 2022 and is anticipated to reach US$ 485120 million by 2029, witnessing a CAGR of 6.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Nutraceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-Pacific market for Nutraceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the...Read more	USD 2,900.00
Vitamins and Supplements 麻豆原创s in China China's demand for Vitamins and Supplements has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry...Read more	USD 4,000.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创